FDA Inspection 1171416 — Central Iowa Health System

Central Iowa Health System — FEI 1970357

The FDA completed an inspection of Central Iowa Health System on May 12, 2022 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Des Moines, IA (United States)